Celanese Corp Files 2023 Annual Report on Form 10-K
Ticker: CE · Form: 10-K · Filed: Feb 23, 2024 · CIK: 1306830
| Field | Detail |
|---|---|
| Company | Celanese CORP (CE) |
| Form Type | 10-K |
| Filed Date | Feb 23, 2024 |
| Risk Level | |
| Pages | 14 |
| Reading Time | 17 min |
| Key Dollar Amounts | $0.0001, $11.0 b, $503 million |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, Annual Report, Celanese Corp, Financials, SEC Filing
TL;DR
<b>Celanese Corp filed its 2023 10-K, detailing its financial position and business operations.</b>
AI Summary
Celanese Corp (CE) filed a Annual Report (10-K) with the SEC on February 23, 2024. Celanese Corp reported total assets of $12,564,643,206 for the fiscal year ending December 31, 2023. The company's fiscal year ends on December 31st. Celanese Corp is incorporated in Delaware. The company's principal business address is 222 W. Las Colinas Blvd., Suite 900N, Irving, TX 75039-5421. The filing is a 10-K annual report.
Why It Matters
For investors and stakeholders tracking Celanese Corp, this filing contains several important signals. This 10-K filing provides a comprehensive overview of Celanese Corp's financial health and strategic direction for the fiscal year 2023, crucial for investors assessing performance and future prospects. Understanding the company's reported assets and fiscal year-end provides a baseline for evaluating its financial stability and operational scale.
Risk Assessment
Risk Level: — Celanese Corp shows moderate risk based on this filing. The filing is a standard annual report (10-K) and does not contain immediate red flags, indicating a routine disclosure of financial information.
Analyst Insight
Review the detailed financial statements and risk factors within the 10-K to understand Celanese Corp's performance and potential challenges.
Financial Highlights
- revenue
- 108,906,426
- total Assets
- 12,564,643,206
Key Numbers
- 12,564,643,206 — Total Assets (As of December 31, 2023)
- 2023-12-31 — Fiscal Year End (Reporting Period)
Key Players & Entities
- Celanese Corp (company) — Filer
- 2023 (date) — Fiscal Year End
- December 31, 2023 (date) — Fiscal Year End
- 2024-02-23 (date) — Filing Date
- Delaware (location) — State of Incorporation
- 222 W. Las Colinas Blvd., Suite 900N (address) — Business Address
- Irving (location) — Business Address City
- TX (location) — Business Address State
FAQ
When did Celanese Corp file this 10-K?
Celanese Corp filed this Annual Report (10-K) with the SEC on February 23, 2024.
What is a 10-K filing?
A 10-K is a comprehensive annual financial report required by the SEC, covering audited financials, business operations, risk factors, and management discussion. This particular 10-K was filed by Celanese Corp (CE).
Where can I read the original 10-K filing from Celanese Corp?
You can access the original filing directly on the SEC's EDGAR system. The filing is publicly available and includes all exhibits and attachments submitted by Celanese Corp.
What are the key takeaways from Celanese Corp's 10-K?
Celanese Corp filed this 10-K on February 23, 2024. Key takeaways: Celanese Corp reported total assets of $12,564,643,206 for the fiscal year ending December 31, 2023.. The company's fiscal year ends on December 31st.. Celanese Corp is incorporated in Delaware..
Is Celanese Corp a risky investment based on this filing?
Based on this 10-K, Celanese Corp presents a moderate-risk profile. The filing is a standard annual report (10-K) and does not contain immediate red flags, indicating a routine disclosure of financial information.
What should investors do after reading Celanese Corp's 10-K?
Review the detailed financial statements and risk factors within the 10-K to understand Celanese Corp's performance and potential challenges. The overall sentiment from this filing is neutral.
How does Celanese Corp compare to its industry peers?
Celanese Corporation operates in the chemical industry, focusing on producing and selling differentiated chemistry solutions and specialty materials.
Are there regulatory concerns for Celanese Corp?
The filing is made in accordance with the Securities Exchange Act of 1934, requiring public companies to submit annual reports.
Industry Context
Celanese Corporation operates in the chemical industry, focusing on producing and selling differentiated chemistry solutions and specialty materials.
Regulatory Implications
The filing is made in accordance with the Securities Exchange Act of 1934, requiring public companies to submit annual reports.
What Investors Should Do
- Analyze the detailed financial statements for revenue, net income, and cash flow.
- Review the Management's Discussion and Analysis for insights into business performance and outlook.
- Examine the Risk Factors section for potential challenges and uncertainties facing the company.
Key Dates
- 2023-12-31: Fiscal Year End — End of the reporting period for the 10-K filing.
Year-Over-Year Comparison
This is the 2023 10-K filing, representing the company's annual disclosure for the most recent fiscal year.
Filing Stats: 4,205 words · 17 min read · ~14 pages · Grade level 15.2 · Accepted 2024-02-23 16:19:23
Key Financial Figures
- $0.0001 — ich Registered Common Stock, par value $0.0001 per share CE New York Stock Exchange
- $11.0 b — n was completed for a purchase price of $11.0 billion, subject to transaction adjustmen
- $503 million — dients business for a purchase price of $503 million. See Note 4 - Acquisitions, Disposition
Filing Documents
- ce-20231231.htm (10-K) — 3358KB
- ex411-10k123123.htm (EX-4.11) — 243KB
- ex109a10-k123123.htm (EX-10.9(A)) — 115KB
- ex1010b1-10k123123.htm (EX-10.10(B) 1) — 2KB
- ex1014-10k123123.htm (EX-10.14) — 2KB
- ex211-10k123123.htm (EX-21.1) — 147KB
- ex221-10k123123.htm (EX-22.1) — 10KB
- ex231-10k123123.htm (EX-23.1) — 2KB
- ex311-10k123123.htm (EX-31.1) — 11KB
- ex312-10k123123.htm (EX-31.2) — 11KB
- ex321-10k123123.htm (EX-32.1) — 6KB
- ex322-10k123123.htm (EX-32.2) — 6KB
- ex97123123.htm (EX-97) — 28KB
- ce-20231231_g1.gif (GRAPHIC) — 22KB
- ce-20231231_g2.jpg (GRAPHIC) — 147KB
- celaneselogo2a.jpg (GRAPHIC) — 34KB
- 0001306830-24-000029.txt ( ) — 20511KB
- ce-20231231.xsd (EX-101.SCH) — 115KB
- ce-20231231_cal.xml (EX-101.CAL) — 168KB
- ce-20231231_def.xml (EX-101.DEF) — 639KB
- ce-20231231_lab.xml (EX-101.LAB) — 1415KB
- ce-20231231_pre.xml (EX-101.PRE) — 1032KB
- ce-20231231_htm.xml (XML) — 3814KB
Business
Business 4 Item 1A.
Risk Factors
Risk Factors 17 Item 1B. Unresolved Staff Comments 29 Item 1C. Cybersecurity 29 Item 2.
Properties
Properties 30 Item 3.
Legal Proceedings
Legal Proceedings 31 Item 4. Mine Safety Disclosures 31 Information about our Executive Officers 31 PART II Item 5. Market for the Registrant's Common Equity, Related Shareholder Matters and Issuer Purchases of Equity Securities 33 Item 6. Reserved 34 Item 7.
Management's Discussion and Analysis of Financial Condition and Results of Operations
Management's Discussion and Analysis of Financial Condition and Results of Operations 35 Item 7A.
Quantitative and Qualitative Disclosures About Market Risk
Quantitative and Qualitative Disclosures About Market Risk 50 Item 8.
Financial Statements and Supplementary Data
Financial Statements and Supplementary Data 51 Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure 51 Item 9A.
Controls and Procedures
Controls and Procedures 51 Item 9B. Other Information 52 Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections 52 PART III Item 10. Directors, Executive Officers and Corporate Governance 53 Item 11.
Executive Compensation
Executive Compensation 53 Item 12.
Security Ownership of Certain Beneficial Owners and Management and Related Shareholder Matters
Security Ownership of Certain Beneficial Owners and Management and Related Shareholder Matters 53 Item 13. Certain Relationships and Related Transactions, and Director Independence 53 Item 14. Principal Accounting Fees and Services 53 PART IV Item 15. Exhibits and Financial Statement Schedules 54
Signatures
Signatures 59 2 Table of Contents Special Note Regarding Forward-Looking Statements Certain statements in this Annual Report on Form 10-K ("Annual Report") or in other materials we have filed or will file with the Securities and Exchange Commission ("SEC"), and incorporated herein by reference, are forward-looking in nature as defined in Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. You can identify these statements by the fact that they do not relate to matters of a strictly factual or historical nature and generally discuss or relate to forecasts, estimates or other expectations regarding future events. Generally, the words "believe," "expect," "intend," "estimate," "anticipate," "project," "plan," "may," "can," "could," "might," "will" and similar expressions identify forward-looking statements, including statements that relate to such matters as planned and expected capacity increases and utilization rates; anticipated capital spending; environmental matters; legal proceedings; sources of raw materials and exposure to, and effects of hedging of raw material and energy costs and foreign currencies; interest rate fluctuations; global and regional economic, political, business and regulatory conditions; expectations, strategies, and plans for individual assets and products, business segments, as well as for the whole Company; cash requirements and uses of available cash; financing plans; pension expenses and funding; anticipated restructuring, divestiture, and consolidation activities; planned construction or operation of facilities; cost reduction and control efforts and targets and integration of acquired businesses. Forward-looking statements are not historical facts or guarantees of future performance but instead represent only our beliefs at the time the statements were made regarding future events, which are subject to si
Business
Item 1. Business Basis of Presentation In this Annual Report on Form 10-K, the term "Celanese" refers to Celanese Corporation, a Delaware corporation, and not its subsidiaries. The terms "Company," "we," "our" and "us" refer to Celanese and its subsidiaries on a consolidated basis. The term "Celanese U.S." refers to the Company's subsidiary, Celanese US Holdings LLC, a Delaware limited liability company, and not its subsidiaries. Industry This Annual Report on Form 10-K includes industry data obtained from industry publications and surveys, as well as our own internal company surveys. Third-party industry publications, surveys and forecasts generally state that the information contained therein has been obtained from sources believed to be reliable. Overview We are a global chemical and specialty materials company. We are a leading global producer of high performance engineered polymers that are used in a variety of high-value applications, as well as one of the world's largest producers of acetyl products, which are intermediate chemicals for nearly all major industries. As a recognized innovator in the chemicals industry, we engineer and manufacture a wide variety of products essential to everyday living. Our broad product portfolio serves a diverse set of end-use applications including automotive, chemical additives, construction, consumer and industrial adhesives, medical, consumer electronics, energy storage, filtration, paints and coatings, paper and packaging, industrial applications and textiles. Our products enjoy leading global positions due to our differentiated business models, large global production capacity, operating efficiencies, proprietary technology and competitive cost structures. Our large and diverse global customer base primarily consists of major companies across a broad array of industries. We hold geographically balanced global positions and participate in diversified end-use applications. We combine a demonstrated track record of e